Andrew Booth

Insider Reports History

Location
Vancouver, British Columbia, Canada
Signature
Tryn Stimart, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Booth:

Company Role Class Num Shares Value Price $ Report Date Ownership
AbCellera Biologics Inc. Chief Financial Officer Common Shares 195,600 $668,952 $3.42 27 Feb 2026 Direct
AbCellera Biologics Inc. Chief Financial Officer Common Shares 130,959 $505,501 $3.86 27 Feb 2026 By spouse
AbCellera Biologics Inc. Chief Financial Officer Share option (right to buy) 8,751,849 01 Jan 2026 Direct

Insider Reports Filed by Andrew Booth

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ABCL AbCellera Biologics Inc. 27 Feb 2026 1 +$145,692 4 Chief Financial Officer 27 Feb 2026, 14:48
ABCL AbCellera Biologics Inc. 01 Jan 2026 1 $0 4 Chief Financial Officer 05 Jan 2026, 12:11
ABCL AbCellera Biologics Inc. 01 Jan 2025 1 $0 4 Chief Financial Officer 03 Jan 2025, 15:37
ABCL AbCellera Biologics Inc. 14 Jan 2024 1 $0 4 Chief Financial Officer 16 Jan 2024, 18:18
ABCL AbCellera Biologics Inc. 26 May 2023 1 +$99,325 4 Chief Financial Officer 26 May 2023, 14:53
ABCL AbCellera Biologics Inc. 20 Dec 2022 3 +$9,500 4 Chief Financial Officer 22 Dec 2022, 13:31
ABCL AbCellera Biologics Inc. 01 Dec 2022 1 $0 4 Chief Financial Officer 05 Dec 2022, 11:19
ABCL AbCellera Biologics Inc. 12 May 2022 1 +$492,150 4 Chief Financial Officer 16 May 2022, 14:13
ABCL AbCellera Biologics Inc. 31 Dec 2021 1 $0 5 Chief Financial Officer 03 Feb 2022, 17:54
ABCL AbCellera Biologics Inc. 10 Dec 2021 2 +$160,000 4 Chief Financial Officer 10 Dec 2021, 16:00
ABCL AbCellera Biologics Inc. 07 Dec 2021 1 $0 4 Chief Financial Officer 09 Dec 2021, 16:58
ABCL AbCellera Biologics Inc. 11 Nov 2021 2 +$993,130 4 Chief Financial Officer 15 Nov 2021, 05:05
ABCL AbCellera Biologics Inc. 09 Jun 2021 1 -$30,600,000 4 Chief Financial Officer 10 Jun 2021, 17:00
ABCL AbCellera Biologics Inc. 07 Jun 2021 4 +$306,000 4 Chief Financial Officer 09 Jun 2021, 20:30